Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-09-13
2005-09-13
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200
Reexamination Certificate
active
06943151
ABSTRACT:
Disclosed are methods of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related Compounds. The invention has a wide spectrum of important uses including hyperparathyroidism, Paget's disease, hypercalcemia of malignancy, osteolytic lesions produced by bone metastasis, bone loss due to immobilisation or sex hormone deficiency, osteomalacia, hyperostosis and osteopetrosis.
REFERENCES:
patent: 6770620 (2004-08-01), Henriksen
patent: 0 955 314 (1999-11-01), None
patent: WO 96/32414 (1996-10-01), None
patent: WO 97/31943 (1997-09-01), None
patent: WO 98/24813 (1998-06-01), None
patent: WO 98/52600 (1998-11-01), None
patent: WO 99/14239 (1999-03-01), None
patent: WO 00/34331 (2000-06-01), None
patent: WO 00/34332 (2000-06-01), None
patent: WO 01/41779 (2001-06-01), None
patent: WO 01/87322 (2001-11-01), None
patent: WO 01/98331 (2001-12-01), None
patent: WO 02/10195 (2002-02-01), None
patent: WO 02/24214 (2002-03-01), None
patent: WO 02/066062 (2002-08-01), None
Haderslev et al. Does Short-Term Administration of Glucagon-Like Peptide Type 2 . . . Gastroenterology. Apr. 2001, vol. 120, No. 5, Supplement 1, p. A-314, Abstract 1619.
Francis, Roger M., “Bisphosphonates in the Treatment of Osteoporosis in 1997: A Review”; Current Therapeutic Research, vol. 58, pp. 656-678, No. 10, Oct. 1997.
Haderslev, K. V. et al., “Short-term Administration of Gluagon-like Peptide-2. Effects on Bone Mineral Density and Markers of Bone Turnover in Short-Bowel Patients with No Colon”; Taylor & Francis Healthsciences, pp. 392-398. Scandinavian J. of Gastroenterology, vol. 37, No. 4 (Apr. 2002).
Henriksen Dennis B.
Holst Jens J.
Buchanan Robert L.
Butler Gregory B.
Edwards & Angell, LLP.
Russel Jeffrey Edwin
Sanos Bioscience A/S
LandOfFree
Method of inhibiting bone resorption and/or promoting bone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting bone resorption and/or promoting bone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting bone resorption and/or promoting bone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3382108